Commentary / Open Access

DOI: 10.31488 /heph.148

Lung Injury Associated with the Use of E-Cigarette - (Evali) in theCovid-19 Context

RebecaRolim de Britoa1, Ana WalleskaLeite Diniza1, Tamara Moraes Soriano Vieiraa1, CamilaBezerra Nobrea1, Modesto lLeiteRolimNeto*1

  1. School of Medicine of Juazeiro do Norte (FMJ/Estácio) – Juazeiro do Norte, Ceará, Brazil

*Corresponding author: Modesto Leite Rolim Neto,School of Medicine,Federal University of Cariri,UFCA,Barbalha, Ceará, Brazil.

Abstract

In October of 2019, the Centers for Disease Control and Prevention (CDC) in the USA called e-cigarette or vaping product use-associated lung injury as EVALI, whose symptoms are very similar to flu ones.In face of the current COVID- 19 pandemic, we need to highlight important similarities between these two lung diseases.Method: Studies were identified using large-circulation international journals found in two electronic databases: Scopus and Embase.. The data was also compared with information from the main international newspapers.Results: Antidepressant effects caused vaping, are associated with the increase of such device use during the pandemic as a way to relieve the mental diseases symptoms.Conclusions: Vaping has been used more frequently during the social isolation period, especially due to cannabidiol and antidepressant proprieties, which shows the EVALI importance in pandemic periods.

Keywords: 2019 coronavirus disease (COVID-19),E-cigarette,Vaping, EVALI.

Introduction

In October of 2019, the Centers for Disease Control and Prevention (CDC) in the USA called e-cigarette or vaping product use-associated lung injury as EVALI, whose symptoms are very similar to flu ones, but they can take patients to Intensive Care Units or lead to death [1]. Based on the principle that vaping arose as a healthier alternative for smokers to help them abandon tobacco addiction and, secondarily, as a recreational use, the appearance of e-cigarette-related deaths in the United States in 2019 justify the prohibition of these devices in some countries like India and Brazil [2].

Hence, more than 3 million North American young subjects have statedusing e-cigarette in the last 30 days, and North American authorities claim there are not sufficient data to state that e-cigarette is less harmful than tobacco cigarette [3].2,807 EVALI cases or deaths were reported in the USA in February of 2020 [4].Under these circumstances, an analysis should be carried out on the increase of EVALI cases due to the aggravated use of e-cigarette, considering it is a flu syndrome that results in serious complications and has similar symptoms of other diseases including COVID-19.

Contextual clues in the EVALI clinical context, during the diagnosis interview, should not only assess respiratory symptoms (cough, dyspnea), gastrointestinal symptoms (pain, nausea, vomiting, diarrhea) and non-specific symptoms (fever, shiver, weight loss), but also question on the e-cigarette use, type, and where it was found.The CDC highlight the identification of Vitamin E acetate and tetrahydrocannabinol (THC) as one of the main components responsible for EVALI and, therefore, recommendthat users do not use vaping containing these additives mainly from online purchase or known resellers4.Confirmed cases present clinical symptoms, vapinguse in the last 90 days with radiography consolidations or frosted glass in chest tomography and no infectious diseases with viral panel and negative PCR [5].

In face of the current COVID- 19 pandemic, we need to highlight important similarities between these two lung diseases.The World Health Organization [6] states this is an acute respiratory disease, whose main symptoms include fever, dry cough, nasal congestion, diarrhea and shortness of breath, which may take the patient to the hospital due to breathing difficulties or chest pressure/tightness [7].The radiographic pattern shows a predominance of alveolar alterations, opacity in frosted glass, focal consolidations and mixed opacities [8].Thus, it is constituted as a flu syndrome like the EVALI, which may evolve to acute respiratory syndrome.

A lot of conflicting information arose last year on the positive and negative sides of using e-cigarette, which made the community of users, mainly young subjects, very confused.In addition, part of vaping users are not aware of the e-cigarette formula components and use it mainly based on its discrete appearance, high rate of nicotine in the products, and presence of flavored vapors, which is another quite attractive characteristic to the young audience [9].Isolation measures and global surveillance aimed at containing the COVID-19 pandemic lead to a crisis in illegal drug traffic, with a price increase and purity decrease [10].Thus, it has been observed that users have sought other drugs as alternatives for this period, such as benzodiazepine, alcohol, and tobacco [5] that increased the use of e-cigarettes all over the world [11].

Therefore, the increase of e-cigarette use may be potentially correlated with the current global scenario.From this perspective, we can highlight a research made by the YoungMinds Institute. It emphasizes that the pandemic has been causing great repercussions on young subjects’ mental health [12]. This can be analyzed under the view that, with social distancing applied in many countries due to the COVID-19 pandemic, many young subjects have been suffering with routine changes and privation of living with friends and family, as well as privation of outdoor leisure activities, which causes anxiety and depression crises in many of them.Additionally, antidepressant effects caused by CBD vaping, as stated by the WHO, are associated with the increase of such device use during the pandemic as a way to relieve these mental diseases symptoms [7].With social distance, many young subjects amidst anxiety and depression crises inherent to brain serotonin decrease intensity of CBD vapinguse with the aim of increasing these serotonin levels [13].

Thus, the similarity of signs and symptoms between both pathologies and the importance of EVALI disclosure in an international, mediatic and academic scope become clinical indicators, so that questions regarding the use of e-cigarette be added during diagnosis of a respiratory syndrome.Furthermore, surveillance as to the nature and quality of substances used in the e-cigarette should be further improved, in order that there is a better control on the use of this device, both for smokers that want to abandon this traditional cigarette and for young subjects that use it for fun.Also, vaping has been used more frequently during the social isolation period, especially due to cannabidiol and antidepressant proprieties, which shows the EVALI importance in pandemic periods.

Authors’ contributions

MLRN and CBN designed the review, developed the inclusion criteria, screened titles and abstracts, appraised the quality of included papers, and drafted the manuscript.MLRN, RBB, AWLD, TMSV and CBN reviewed the study protocol and inclusion criteria and provided substantial input to the manuscript.MLRN reviewed the study protocol. MLRN read and screened articles for inclusion. All authors critically reviewed drafts and approved the final manuscript.

Acknowledgements

The authors would like to thank the Research Group: Suicidology – Universidade Federal doCeará (UFC) and Brazilian National Council for Scientific and Technological Development (CNPq) – institution linked to the Brazilian Department of Science, Technology and Scientific Writing Lab, Medicine School – Universidade Federal of Cariri (UFCA).

Funding

TheResearch Group: Suicidology – Universidade Federal do Ceará (UFC) and Brazilian National Council for Scientific and Technological Development (CNPq) – institution linked to the Brazilian Department of Science, Technology,and Innovation to encourage research in Brazil.

Conflict of interests

The authors declare that they have no competing interests.

References

  1. Scientific America.Vaping-Related Illness Has a New Name: EVALI.2019.

  2. Reuteres.Could life insurance go up in smoke for some vapers?2019.

  3. The Independent. Mistery lung illness linked to vapingreporterd in nearly 100 people.2019.

  4. Centers for Disease Control and Prevention (CDC),Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. 2020.

  5. Sociedade Brasileira de Pneumologia e Tisiologia (SBPT), Injúria pulmonar relacionada ao uso de cigarro eletrônico (EVALI). 2020.

  6. WHO.Medidas contra COVID-19 provocam alta dos preços de drogas ilícitas no mundo.2020.

  7. BBC. Sintomas do coronavírus: quais os novos sinais de covid-19 que as autoridades americanas acrescentaram à lista. 2020.

  8. Araujo-Filho JA, Sawamura MV, Costa AN, et.al. Pneumonia por COVID-19: qual o papel da imagem no diagnóstico? JBrasPneumol.2020;46, e20200114.

  9. Evolution of e-cigarretes: viligance is needed to protect adolescent health. Lancet RespirMed. 2020;8.217.

  10. Organização das Nações Unidas, Medidas contra COVID-19 provocam alta dos preços de drogas ilícitas no mundo.2020.

  11. CNN Brasil,Com escassez durante pandemia, usuários buscam drogas mais fortes e perigosas.2020.

  12. Young Minds. Coronavirus and mental health.2020.

  13. Dar W.Vaping Herald. Benefícios da Vaping CBD, bem como os efeitos. 2020.

Received: June01, 2020;
Accepted: July 07, 2020;
Published: July09, 2020.

To cite this article : de Brito RR, Diniz AWL, Vieira TMS, et al.Lung Injury Associated with the Use of E-Cigarette – (Evali) in the Covid-19 Context.Health Education and Public Health.2020; 3:4.

© de Brito RR, et.al.2020.